نتائج البحث - "Nadia Madrid-Elena"

المصدر: López-Huertas, M R, Morín, M, Madrid-Elena, N, Gutiérrez, C, Jiménez-Tormo, L, Santoyo, J, Sanz-Rodríguez, F, Moreno Pelayo, M Á, Bermejo, L G & Moreno, S 2019, ' Selective miRNA Modulation Fails to Activate HIV Replication in In Vitro Latency Models ', Molecular Therapy-Nucleic Acids, vol. 17, pp. 323-336 . https://doi.org/10.1016/j.omtn.2019.06.006
Molecular Therapy. Nucleic Acids
Biblos-e Archivo. Repositorio Institucional de la UAM
Consejo Superior de Investigaciones Científicas (CSIC)
Molecular Therapy: Nucleic Acids, Vol 17, Iss, Pp 323-336 (2019)

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f129acb19f8e53147e001d0229a0d26c
https://doi.org/10.1016/j.omtn.2019.06.006

View record from ScienceDirect

Find this article in full text from ProQuest

6

Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound

المؤلفون: Rafael Coll Delgado, Santiago Moreno, Carolina Gutierrez, Julián Olalla-Sierra, María Rosa López-Huertas, Rafael M. Rubio, Nadia Madrid-Elena, María Ángeles Muñoz-Fernández, Beatriz Hernández-Novoa, Montserrat Plana

المصدر: Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::460047c40e92b2cab7eb7194b9a199a2
http://europepmc.org/articles/PMC7749169

Find this article in full text from ProQuest

7

Maraviroc reactivates HIV with potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells

المؤلفون: Laura Jiménez-Tormo, Nadia Madrid-Elena, Carolina Gutierrez, María Rosa López-Huertas, María J Vivancos, Laura Luna, Santiago Moreno

المصدر: Biochemical pharmacology. 182

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d3088592acd813d1ea1d228329d901
https://pubmed.ncbi.nlm.nih.gov/32979351

View record from ScienceDirect

8

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1

المؤلفون: Nadia Madrid-Elena, Carolina Gutierrez, José Alcamí, Mayte Coiras, Santiago Moreno, Laura Jiménez-Tormo, María Rosa López-Huertas, Sara Rodríguez-Mora

المصدر: Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Scientific Reports
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repisalud
Instituto de Salud Carlos III (ISCIII)

مصطلحات موضوعية: 0301 basic medicine, Agonist, CD4-Positive T-Lymphocytes, Bryostatin 1, Receptors, CCR5, medicine.drug_class, Science, Primary Cell Culture, CCR5 receptor antagonist, Pharmacology, Biology, Virus Replication, Article, Human herpesvirus-7 encephalitis, Maraviroc, 03 medical and health sciences, chemistry.chemical_compound, medicine, Potency, Humans, Latency (engineering), Receptor, Protein kinase C, Protein Kinase C, Cell Proliferation, Multidisciplinary, Interleukin-7, NF-kappa B, virus diseases, Immunocompetent adults, Bryostatins, Virus Latency, body regions, 030104 developmental biology, chemistry, Gene Expression Regulation, Immunology, CCR5 Receptor Antagonists, Host-Pathogen Interactions, HIV-1, Chemokine CCL19, Medicine, Clinical significance HHV-7 CNS, human activities, Signal Transduction